Shaban K. Mohammed

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Response to Letter to the Editor: Commending the Feasibility of CYP2C19 Pharmacogenetic Testing in Personalized Antiplatelet Therapy-Insights and Perspectives.

Response to Letter to the Editor: Commending the Feasibility of CYP2C19 Pharmacogenetic Testing in Personalized Antiplatelet Therapy-Insights and Perspectives.

Journal: Clinical therapeutics

Published: February 09, 2026

Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients.

Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 02, 2026

Improving the clinical diagnosis of familial hypercholesterolemia among patients attending diabetes and cardiology clinics.

Improving the clinical diagnosis of familial hypercholesterolemia among patients attending diabetes and cardiology clinics.

Journal: American journal of preventive cardiology

Published: December 02, 2025

Toward Personalized Anticoagulation: Clinical Predictors of Early Warfarin Response in Heart Valve Replacement Patients.

Toward Personalized Anticoagulation: Clinical Predictors of Early Warfarin Response in Heart Valve Replacement Patients.

Journal: Biomedicines

Published: November 03, 2025

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.

Journal: Clinical therapeutics

Published: May 19, 2025

Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis.

Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis.

Journal: Frontiers in pharmacology

Published: April 30, 2025

Assessment of knowledge, perceptions, and readiness of healthcare professionals towards clinical pharmacogenomics implementation in Qatar: a mixed-method study.

Assessment of knowledge, perceptions, and readiness of healthcare professionals towards clinical pharmacogenomics implementation in Qatar: a mixed-method study.

Journal: Journal of pharmaceutical policy and practice

Published: November 28, 2024

Exposure to High-Dose Liraglutide in a Pregnant Woman With Obesity.

Exposure to High-Dose Liraglutide in a Pregnant Woman With Obesity.

Journal: O&G open

Published: November 13, 2024

Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar.

Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar.

Journal: Journal of pharmaceutical policy and practice

Published: October 29, 2024

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery: a multi-ancestry study in 10 960 individuals from 9 biobanks.

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery: a multi-ancestry study in 10 960 individuals from 9 biobanks.

Journal: medRxiv : the preprint server for health sciences

Published: September 24, 2024

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.

Journal: Nature medicine

Published: September 03, 2024

A multi-ancestry genome-wide association study and evaluation of polygenic scores of LDL-C levels.

A multi-ancestry genome-wide association study and evaluation of polygenic scores of LDL-C levels.

Journal: Journal of lipid research

Published: August 30, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026